Intracranial WHO grade I meningioma: a competing risk analysis of progression and disease-specific survival View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-11-09

AUTHORS

Charles Champeaux, Deborah Houston, Laurence Dunn, Matthieu Resche-Rigon

ABSTRACT

BackgroundStudies on meningioma are reported with inadequate allowance for competing causes of progression or death. The aim of this study was to describe the outcome of patients with intracranial WHO grade I meningioma and identify factors that may influence disease progression and cause-specific survival.MethodsPathology reports and clinical data of 505 WHO grade I meningiomas treated between January 2003 and December 2017 were retrospectively reviewed at a single institution. We estimated a cumulative incidence function for progression and cause-specific mortality. A competing risk analysis was conducted on clinical and histological criteria. Median follow-up was 6.2 years.ResultsA total of 530 surgical resections were performed on 505 cases. Forty-one patients received radiotherapy (RT). At data collection, 84 patients had died of their meningioma disease or demonstrated a recurrence eventually treated by redo surgery or RT. The risks of recurrence or meningioma-related death at 5 years were 16.2%, 95%CI[12.5, 20], whereas 5-year overall survival was 86.1%, 95%CI[82.8, 89.6]. In the multivariable Fine-Gray regression for a competing risk model, venous sinus invasion (SHR = 1.8, 95%CI[1.1, 2.9], p0.028), extent of resection (SHR = 0.2, 95%CI[0.1, 0.3], p < 0.001), and progressing meningioma (SHR = 7, 95%CI[3.3, 14.8], p < 0.001) were established as independent prognostic factors of cause-specific death or meningioma progression. In contrast, age at diagnosis < 65 years (HR = 1.1, 95%CI[1, 1.1], p < 0.001) and redo surgery for meningioma recurrence (HR = 2.6, 95%CI[1.4, 5], p = 0.00252) were predictors of the overall survival.ConclusionsIn this large series, WHO grade I meningioma treatment failure correlated with venous sinus invasion, incomplete resection, and progressing tumour; shorter survival correlated with increased age and redo surgery for recurrence. We recommend the cumulative incidence competing risk approach in WHO grade I meningioma studies where unrelated mortality may be substantial, as this approach results in more accurate estimates of disease risk and associated predictors. More... »

PAGES

2541-2549

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00701-019-04096-9

DOI

http://dx.doi.org/10.1007/s00701-019-04096-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1122462639

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/31707459


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Neurosurgery, Lariboisi\u00e8re Hospital, 2, rue Ambroise-Par\u00e9, Cedex 10, 75475, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.411296.9", 
          "name": [
            "Department of Neurosurgery, Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, UK", 
            "INSERM U1153, Statistic and Epidemiologic Research Centre Sorbonne Paris Cite (CRESS), ECSTRA team, Universite Diderot - Paris 7, USPC, Paris, France", 
            "Department of Neurosurgery, Lariboisi\u00e8re Hospital, 2, rue Ambroise-Par\u00e9, Cedex 10, 75475, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Champeaux", 
        "givenName": "Charles", 
        "id": "sg:person.0675443475.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675443475.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neurosurgery, Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, UK", 
          "id": "http://www.grid.ac/institutes/grid.511123.5", 
          "name": [
            "Department of Neurosurgery, Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Houston", 
        "givenName": "Deborah", 
        "id": "sg:person.014600520677.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014600520677.62"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neurosurgery, Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, UK", 
          "id": "http://www.grid.ac/institutes/grid.511123.5", 
          "name": [
            "Department of Neurosurgery, Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dunn", 
        "givenName": "Laurence", 
        "id": "sg:person.01230762673.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01230762673.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "INSERM U1153, Statistic and Epidemiologic Research Centre Sorbonne Paris Cite (CRESS), ECSTRA team, Universite Diderot - Paris 7, USPC, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.508487.6", 
          "name": [
            "INSERM U1153, Statistic and Epidemiologic Research Centre Sorbonne Paris Cite (CRESS), ECSTRA team, Universite Diderot - Paris 7, USPC, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Resche-Rigon", 
        "givenName": "Matthieu", 
        "id": "sg:person.01036155166.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036155166.50"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/978-3-319-19425-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003743887", 
          "https://doi.org/10.1007/978-3-319-19425-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00401-016-1545-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021788062", 
          "https://doi.org/10.1007/s00401-016-1545-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.2013.714", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026565182", 
          "https://doi.org/10.1038/bjc.2013.714"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bmt.2009.359", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015995228", 
          "https://doi.org/10.1038/bmt.2009.359"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-017-2659-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092688951", 
          "https://doi.org/10.1007/s11060-017-2659-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-016-2181-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027421322", 
          "https://doi.org/10.1007/s11060-016-2181-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-4757-3294-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023222883", 
          "https://doi.org/10.1007/978-1-4757-3294-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00701-014-2156-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049770388", 
          "https://doi.org/10.1007/s00701-014-2156-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6602102", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013118273", 
          "https://doi.org/10.1038/sj.bjc.6602102"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1705727", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009895179", 
          "https://doi.org/10.1038/sj.bmt.1705727"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41598-019-42451-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1113378326", 
          "https://doi.org/10.1038/s41598-019-42451-z"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-11-09", 
    "datePublishedReg": "2019-11-09", 
    "description": "BackgroundStudies on meningioma are reported with inadequate allowance for competing causes of progression or death. The aim of this study was to describe the outcome of patients with intracranial WHO grade I meningioma and identify factors that may influence disease progression and cause-specific survival.MethodsPathology reports and clinical data of 505 WHO grade I meningiomas treated between January 2003 and December 2017 were retrospectively reviewed at a single institution. We estimated a cumulative incidence function for progression and cause-specific mortality. A competing risk analysis was conducted on clinical and histological criteria. Median follow-up was 6.2 years.ResultsA total of 530 surgical resections were performed on 505 cases. Forty-one patients received radiotherapy (RT). At data collection, 84 patients had died of their meningioma disease or demonstrated a recurrence eventually treated by redo surgery or RT. The risks of recurrence or meningioma-related death at 5 years were 16.2%, 95%CI[12.5, 20], whereas 5-year overall survival was 86.1%, 95%CI[82.8, 89.6]. In the multivariable Fine-Gray regression for a competing risk model, venous sinus invasion (SHR = 1.8, 95%CI[1.1, 2.9], p0.028), extent of resection (SHR = 0.2, 95%CI[0.1, 0.3], p < 0.001), and progressing meningioma (SHR = 7, 95%CI[3.3, 14.8], p < 0.001) were established as independent prognostic factors of cause-specific death or meningioma progression. In contrast, age at diagnosis < 65 years (HR = 1.1, 95%CI[1, 1.1], p < 0.001) and redo surgery for meningioma recurrence (HR = 2.6, 95%CI[1.4, 5], p = 0.00252) were predictors of the overall survival.ConclusionsIn this large series, WHO grade I meningioma treatment failure correlated with venous sinus invasion, incomplete resection, and progressing tumour; shorter survival correlated with increased age and redo surgery for recurrence. We recommend the cumulative incidence competing risk approach in WHO grade I meningioma studies where unrelated mortality may be substantial, as this approach results in more accurate estimates of disease risk and associated predictors.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00701-019-04096-9", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1412990", 
        "issn": [
          "0001-6268", 
          "0942-0940"
        ], 
        "name": "Acta Neurochirurgica", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "161"
      }
    ], 
    "keywords": [
      "grade I", 
      "redo surgery", 
      "venous sinus invasion", 
      "overall survival", 
      "sinus invasion", 
      "multivariable Fine-Gray regression", 
      "outcomes of patients", 
      "cause-specific survival", 
      "disease-specific survival", 
      "independent prognostic factor", 
      "cause of progression", 
      "Fine-Gray regression", 
      "cause-specific death", 
      "risk of recurrence", 
      "extent of resection", 
      "cause-specific mortality", 
      "grade I meningiomas", 
      "cumulative incidence function", 
      "unrelated mortality", 
      "incomplete resection", 
      "surgical resection", 
      "cumulative incidence", 
      "prognostic factors", 
      "treatment failure", 
      "shorter survival", 
      "single institution", 
      "ResultsA total", 
      "disease progression", 
      "meningioma disease", 
      "clinical data", 
      "histological criteria", 
      "I meningiomas", 
      "large series", 
      "meningioma recurrence", 
      "recurrence", 
      "disease risk", 
      "resection", 
      "patients", 
      "surgery", 
      "radiotherapy", 
      "meningiomas", 
      "progression", 
      "meningioma progression", 
      "survival", 
      "death", 
      "incidence function", 
      "mortality", 
      "age", 
      "risk", 
      "predictors", 
      "invasion", 
      "risk model", 
      "years", 
      "MethodsPathology", 
      "tumors", 
      "BackgroundStudies", 
      "incidence", 
      "disease", 
      "diagnosis", 
      "risk approach", 
      "outcomes", 
      "factors", 
      "total", 
      "ConclusionsIn", 
      "cause", 
      "study", 
      "inadequate allowance", 
      "data collection", 
      "failure", 
      "regression", 
      "aim", 
      "risk analysis", 
      "criteria", 
      "cases", 
      "contrast", 
      "analysis", 
      "function", 
      "extent", 
      "data", 
      "institutions", 
      "more accurate estimates", 
      "series", 
      "collection", 
      "approach", 
      "allowance", 
      "accurate estimates", 
      "estimates", 
      "model"
    ], 
    "name": "Intracranial WHO grade I meningioma: a competing risk analysis of progression and disease-specific survival", 
    "pagination": "2541-2549", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1122462639"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00701-019-04096-9"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "31707459"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00701-019-04096-9", 
      "https://app.dimensions.ai/details/publication/pub.1122462639"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:45", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_798.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00701-019-04096-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00701-019-04096-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00701-019-04096-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00701-019-04096-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00701-019-04096-9'


 

This table displays all metadata directly associated to this object as RDF triples.

222 TRIPLES      21 PREDICATES      124 URIs      105 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00701-019-04096-9 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N6f236905a0de454dae4d5b9b765ae1f9
4 schema:citation sg:pub.10.1007/978-1-4757-3294-8
5 sg:pub.10.1007/978-3-319-19425-7
6 sg:pub.10.1007/s00401-016-1545-1
7 sg:pub.10.1007/s00701-014-2156-z
8 sg:pub.10.1007/s11060-016-2181-2
9 sg:pub.10.1007/s11060-017-2659-6
10 sg:pub.10.1038/bjc.2013.714
11 sg:pub.10.1038/bmt.2009.359
12 sg:pub.10.1038/s41598-019-42451-z
13 sg:pub.10.1038/sj.bjc.6602102
14 sg:pub.10.1038/sj.bmt.1705727
15 schema:datePublished 2019-11-09
16 schema:datePublishedReg 2019-11-09
17 schema:description BackgroundStudies on meningioma are reported with inadequate allowance for competing causes of progression or death. The aim of this study was to describe the outcome of patients with intracranial WHO grade I meningioma and identify factors that may influence disease progression and cause-specific survival.MethodsPathology reports and clinical data of 505 WHO grade I meningiomas treated between January 2003 and December 2017 were retrospectively reviewed at a single institution. We estimated a cumulative incidence function for progression and cause-specific mortality. A competing risk analysis was conducted on clinical and histological criteria. Median follow-up was 6.2 years.ResultsA total of 530 surgical resections were performed on 505 cases. Forty-one patients received radiotherapy (RT). At data collection, 84 patients had died of their meningioma disease or demonstrated a recurrence eventually treated by redo surgery or RT. The risks of recurrence or meningioma-related death at 5 years were 16.2%, 95%CI[12.5, 20], whereas 5-year overall survival was 86.1%, 95%CI[82.8, 89.6]. In the multivariable Fine-Gray regression for a competing risk model, venous sinus invasion (SHR = 1.8, 95%CI[1.1, 2.9], p0.028), extent of resection (SHR = 0.2, 95%CI[0.1, 0.3], p < 0.001), and progressing meningioma (SHR = 7, 95%CI[3.3, 14.8], p < 0.001) were established as independent prognostic factors of cause-specific death or meningioma progression. In contrast, age at diagnosis < 65 years (HR = 1.1, 95%CI[1, 1.1], p < 0.001) and redo surgery for meningioma recurrence (HR = 2.6, 95%CI[1.4, 5], p = 0.00252) were predictors of the overall survival.ConclusionsIn this large series, WHO grade I meningioma treatment failure correlated with venous sinus invasion, incomplete resection, and progressing tumour; shorter survival correlated with increased age and redo surgery for recurrence. We recommend the cumulative incidence competing risk approach in WHO grade I meningioma studies where unrelated mortality may be substantial, as this approach results in more accurate estimates of disease risk and associated predictors.
18 schema:genre article
19 schema:isAccessibleForFree false
20 schema:isPartOf Nd626acb6dbca45308584602f9d12f7fe
21 Nfcd61b6c30ec41afa9fe66cb9ee5e84a
22 sg:journal.1412990
23 schema:keywords BackgroundStudies
24 ConclusionsIn
25 Fine-Gray regression
26 I meningiomas
27 MethodsPathology
28 ResultsA total
29 accurate estimates
30 age
31 aim
32 allowance
33 analysis
34 approach
35 cases
36 cause
37 cause of progression
38 cause-specific death
39 cause-specific mortality
40 cause-specific survival
41 clinical data
42 collection
43 contrast
44 criteria
45 cumulative incidence
46 cumulative incidence function
47 data
48 data collection
49 death
50 diagnosis
51 disease
52 disease progression
53 disease risk
54 disease-specific survival
55 estimates
56 extent
57 extent of resection
58 factors
59 failure
60 function
61 grade I
62 grade I meningiomas
63 histological criteria
64 inadequate allowance
65 incidence
66 incidence function
67 incomplete resection
68 independent prognostic factor
69 institutions
70 invasion
71 large series
72 meningioma disease
73 meningioma progression
74 meningioma recurrence
75 meningiomas
76 model
77 more accurate estimates
78 mortality
79 multivariable Fine-Gray regression
80 outcomes
81 outcomes of patients
82 overall survival
83 patients
84 predictors
85 prognostic factors
86 progression
87 radiotherapy
88 recurrence
89 redo surgery
90 regression
91 resection
92 risk
93 risk analysis
94 risk approach
95 risk model
96 risk of recurrence
97 series
98 shorter survival
99 single institution
100 sinus invasion
101 study
102 surgery
103 surgical resection
104 survival
105 total
106 treatment failure
107 tumors
108 unrelated mortality
109 venous sinus invasion
110 years
111 schema:name Intracranial WHO grade I meningioma: a competing risk analysis of progression and disease-specific survival
112 schema:pagination 2541-2549
113 schema:productId N1b664964a9674996babd20448ac39e7e
114 N5a6e8d4be9594b2bba7f7785cf9f63b9
115 Na36a6e295e794abda87603b4a07fab0a
116 schema:sameAs https://app.dimensions.ai/details/publication/pub.1122462639
117 https://doi.org/10.1007/s00701-019-04096-9
118 schema:sdDatePublished 2022-10-01T06:45
119 schema:sdLicense https://scigraph.springernature.com/explorer/license/
120 schema:sdPublisher Ndf407f56975f484ca4435a985e99e049
121 schema:url https://doi.org/10.1007/s00701-019-04096-9
122 sgo:license sg:explorer/license/
123 sgo:sdDataset articles
124 rdf:type schema:ScholarlyArticle
125 N1b664964a9674996babd20448ac39e7e schema:name pubmed_id
126 schema:value 31707459
127 rdf:type schema:PropertyValue
128 N5043a33dc2b4465f9b0da06d1e5f969b rdf:first sg:person.014600520677.62
129 rdf:rest Ne5d42141aafd4b85bcf46f4a25bd2e1f
130 N5a6e8d4be9594b2bba7f7785cf9f63b9 schema:name dimensions_id
131 schema:value pub.1122462639
132 rdf:type schema:PropertyValue
133 N6f236905a0de454dae4d5b9b765ae1f9 rdf:first sg:person.0675443475.45
134 rdf:rest N5043a33dc2b4465f9b0da06d1e5f969b
135 Na36a6e295e794abda87603b4a07fab0a schema:name doi
136 schema:value 10.1007/s00701-019-04096-9
137 rdf:type schema:PropertyValue
138 Nc8c68a8f8c0b4aeb89c847d4e58e4272 rdf:first sg:person.01036155166.50
139 rdf:rest rdf:nil
140 Nd626acb6dbca45308584602f9d12f7fe schema:issueNumber 12
141 rdf:type schema:PublicationIssue
142 Ndf407f56975f484ca4435a985e99e049 schema:name Springer Nature - SN SciGraph project
143 rdf:type schema:Organization
144 Ne5d42141aafd4b85bcf46f4a25bd2e1f rdf:first sg:person.01230762673.65
145 rdf:rest Nc8c68a8f8c0b4aeb89c847d4e58e4272
146 Nfcd61b6c30ec41afa9fe66cb9ee5e84a schema:volumeNumber 161
147 rdf:type schema:PublicationVolume
148 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
149 schema:name Medical and Health Sciences
150 rdf:type schema:DefinedTerm
151 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
152 schema:name Clinical Sciences
153 rdf:type schema:DefinedTerm
154 sg:journal.1412990 schema:issn 0001-6268
155 0942-0940
156 schema:name Acta Neurochirurgica
157 schema:publisher Springer Nature
158 rdf:type schema:Periodical
159 sg:person.01036155166.50 schema:affiliation grid-institutes:grid.508487.6
160 schema:familyName Resche-Rigon
161 schema:givenName Matthieu
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036155166.50
163 rdf:type schema:Person
164 sg:person.01230762673.65 schema:affiliation grid-institutes:grid.511123.5
165 schema:familyName Dunn
166 schema:givenName Laurence
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01230762673.65
168 rdf:type schema:Person
169 sg:person.014600520677.62 schema:affiliation grid-institutes:grid.511123.5
170 schema:familyName Houston
171 schema:givenName Deborah
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014600520677.62
173 rdf:type schema:Person
174 sg:person.0675443475.45 schema:affiliation grid-institutes:grid.411296.9
175 schema:familyName Champeaux
176 schema:givenName Charles
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675443475.45
178 rdf:type schema:Person
179 sg:pub.10.1007/978-1-4757-3294-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023222883
180 https://doi.org/10.1007/978-1-4757-3294-8
181 rdf:type schema:CreativeWork
182 sg:pub.10.1007/978-3-319-19425-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003743887
183 https://doi.org/10.1007/978-3-319-19425-7
184 rdf:type schema:CreativeWork
185 sg:pub.10.1007/s00401-016-1545-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021788062
186 https://doi.org/10.1007/s00401-016-1545-1
187 rdf:type schema:CreativeWork
188 sg:pub.10.1007/s00701-014-2156-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1049770388
189 https://doi.org/10.1007/s00701-014-2156-z
190 rdf:type schema:CreativeWork
191 sg:pub.10.1007/s11060-016-2181-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027421322
192 https://doi.org/10.1007/s11060-016-2181-2
193 rdf:type schema:CreativeWork
194 sg:pub.10.1007/s11060-017-2659-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092688951
195 https://doi.org/10.1007/s11060-017-2659-6
196 rdf:type schema:CreativeWork
197 sg:pub.10.1038/bjc.2013.714 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026565182
198 https://doi.org/10.1038/bjc.2013.714
199 rdf:type schema:CreativeWork
200 sg:pub.10.1038/bmt.2009.359 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015995228
201 https://doi.org/10.1038/bmt.2009.359
202 rdf:type schema:CreativeWork
203 sg:pub.10.1038/s41598-019-42451-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1113378326
204 https://doi.org/10.1038/s41598-019-42451-z
205 rdf:type schema:CreativeWork
206 sg:pub.10.1038/sj.bjc.6602102 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013118273
207 https://doi.org/10.1038/sj.bjc.6602102
208 rdf:type schema:CreativeWork
209 sg:pub.10.1038/sj.bmt.1705727 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009895179
210 https://doi.org/10.1038/sj.bmt.1705727
211 rdf:type schema:CreativeWork
212 grid-institutes:grid.411296.9 schema:alternateName Department of Neurosurgery, Lariboisière Hospital, 2, rue Ambroise-Paré, Cedex 10, 75475, Paris, France
213 schema:name Department of Neurosurgery, Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, UK
214 Department of Neurosurgery, Lariboisière Hospital, 2, rue Ambroise-Paré, Cedex 10, 75475, Paris, France
215 INSERM U1153, Statistic and Epidemiologic Research Centre Sorbonne Paris Cite (CRESS), ECSTRA team, Universite Diderot - Paris 7, USPC, Paris, France
216 rdf:type schema:Organization
217 grid-institutes:grid.508487.6 schema:alternateName INSERM U1153, Statistic and Epidemiologic Research Centre Sorbonne Paris Cite (CRESS), ECSTRA team, Universite Diderot - Paris 7, USPC, Paris, France
218 schema:name INSERM U1153, Statistic and Epidemiologic Research Centre Sorbonne Paris Cite (CRESS), ECSTRA team, Universite Diderot - Paris 7, USPC, Paris, France
219 rdf:type schema:Organization
220 grid-institutes:grid.511123.5 schema:alternateName Department of Neurosurgery, Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, UK
221 schema:name Department of Neurosurgery, Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, UK
222 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...